GlaxoSmithKline - 32 Year Stock Price History | GSK

Historical daily share price chart and data for GlaxoSmithKline since 1986 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for GlaxoSmithKline as of October 23, 2018 is 40.63.
GlaxoSmithKline Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 38.7857 35.3976 41.5900 34.0174 40.6300 19.51%
2017 37.5270 35.3341 41.4015 33.2218 33.9982 -2.96%
2016 36.7513 34.4975 40.4773 33.1756 35.0339 1.81%
2015 35.9602 34.2358 40.0192 31.6091 34.4122 -0.36%
2014 39.7083 40.4988 43.8738 33.3712 34.5348 -15.68%
2013 37.4372 32.2579 40.9591 32.1117 40.9591 28.90%
2012 32.2134 32.0145 34.2120 30.2506 31.7755 0.67%
2011 28.1771 25.7655 31.6410 23.8487 31.5649 22.60%
2010 24.4345 26.7396 27.1291 20.6923 25.7458 -2.08%
2009 22.1802 21.8612 26.7022 16.3500 26.2915 19.30%
2008 24.9253 28.2285 30.5861 18.9341 22.0386 -22.27%
2007 29.5634 29.1598 32.4659 26.9344 28.3523 -0.83%
2006 28.7336 26.7368 31.1345 26.3119 28.5908 7.95%
2005 25.2917 24.0863 28.0852 22.6263 26.4850 9.87%
2004 21.2598 22.9417 24.1626 19.5280 24.1066 5.55%
2003 19.5708 18.2284 23.2209 15.6992 22.8388 28.80%
2002 19.8864 22.9102 23.3790 15.3073 17.7314 -22.56%
2001 24.4628 25.2826 26.3410 22.0793 22.8964 -9.63%
2000 24.7451 23.9779 27.8657 19.8521 25.3369 5.06%
1999 25.1241 29.6518 31.5828 20.7871 24.1160 -16.98%
1998 24.3010 19.7413 29.0499 19.7413 29.0499 47.92%
1997 16.2317 12.6590 19.6880 12.1546 19.6388 53.28%
1996 11.1731 10.9381 13.7203 9.2665 12.8123 17.13%
1995 9.0374 7.7611 10.9381 7.0657 10.9381 44.39%
1994 6.7436 7.4933 7.9024 5.7572 7.5752 2.30%
1993 6.5555 8.1587 8.1587 5.1475 7.4046 -8.78%
1992 9.1977 10.6567 11.6197 7.6050 8.1177 -23.54%
1991 7.3025 5.3595 10.6165 5.0726 10.6165 98.87%
1990 4.5093 4.0545 5.6447 3.6010 5.3383 30.40%
1989 3.5422 2.9508 4.1521 2.8358 4.0938 38.74%
1988 2.7180 2.8153 3.0842 2.4063 2.9508 8.37%
1987 3.5117 2.2490 4.4569 2.2490 2.7228 21.07%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $100.437B $38.892B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $372.065B 17.44
Pfizer (PFE) United States $264.129B 15.46
Novartis AG (NVS) Switzerland $201.850B 17.25
Merck (MRK) United States $195.663B 17.28
AbbVie (ABBV) United States $127.608B 12.47
Eli Lilly (LLY) United States $120.319B 22.27
Sanofi (SNY) France $111.710B 14.14
Novo Nordisk (NVO) Denmark $105.365B 16.84
AstraZeneca (AZN) United Kingdom $100.024B 11.00
Bristol-Myers Squibb (BMY) United States $83.165B 15.05